Third national Aboriginal and Torres Strait Islander blood borne viruses and sexually transmissible infections strategy 2010 – 2013.
Canberra: Department of Health and Ageing, Australia
The Third National Aboriginal and Torres Strait Islander Blood Borne Viruses and Sexually Transmissible Infections Strategy was released in March 2010. It is one of a set of five national strategies aimed at reducing the transmission of sexually transmissible infections (STIs) and blood borne viruses (BBVs) and their morbidity, mortality and personal and social impacts.
The strategy highlights ongoing challenges in Aboriginal and Torres Strait Islander communities relating to STIs and BBVs. These include:
sustained and unacceptably high rates of bacterial STIs in many remote communities
the rate of acquisition of HIV and viral hepatitis through injecting drug use
ongoing incidence of HIV infections among men who have sex with men
lack of access for many communities to culturally appropriate primary health care services.
The new priority action areas identified in the strategy are:
annual, routine and systematic testing, treatment and follow-up for bacterial STIs of sexually active Aboriginal and Torres Strait Islander young people
increased access to treatment for Aboriginal and Torres Strait Islander young people who test positive to bacterial STIs;
increased primary prevention activities that seek to reduce the number of new cases of HIV and viral hepatitis among Aboriginal and Torres Strait Islander people who inject drugs
competent and accredited workforces consistent across all jurisdictions to address the scope of work outlined in the strategy.
Best practice in cervical cancer immunisation: report of a roundtable discussion about the impact of the human papillomavirus vaccine in Australia.
Sydney: Cancer Council Australia
This report lists these recommendations and summarises the discussion and presentations from the Cancer Council Australia 2007 roundtable on human papillimavirus (HPV). The national roundtable discussed HPV immunisation and its impact on the National Cervical Screening Program. The aim was to bring leaders in immunisation and screening together to share their expertise, examine the latest evidence and develop recommendations for policy makers.